
Indian Immunologicals Limited is a leading biotechnology company based in Hyderabad, India. It was established in 1987 as a public sector undertaking.
The company is a part of the National Institute of Immunology (NII) and is involved in the research, development, and manufacturing of vaccines and other immunobiological products. It has a strong presence in the Indian market and has also exported its products to several countries.
Indian Immunologicals Limited has a state-of-the-art manufacturing facility in Hyderabad, which is equipped with modern machinery and technology. The facility has been accredited by several international agencies, including the World Health Organization (WHO) and the National Regulatory Authority of India (CDSCO).
Suggestion: Harbinger Knowledge Products
Discover more: Transgene (company)
Institute and Entities
Indian Immunologicals Limited has a strong presence in the country, with a notable entity being the Human Biologicals Institute (HBI). HBI was established in 1999.
HBI is a division of Indian Immunologicals Ltd and is involved in the Human Health Business. It has emerged as a leading player in the vaccine segment in India and Nepal.
IIL has multiple divisions and partnerships, including the Animal Health division, which markets a wide-range of livestock and companion animal health products.
Animal Health

Indian Immunologicals Limited (IIL) is a significant player in the animal health industry.
IIL manufactures animal health vaccines and formulations, holding the position of the third largest animal health player in the Indian market.
The company is also the market leader in veterinary biologicals in India, demonstrating its expertise in this area.
IIL operates one plant that is certified by several reputable organizations, including the World Health Organization (WHO) and the International Organization for Standardization (ISO).
This certification ensures that IIL's products meet the highest standards of quality and safety.
IIL introduced the world's first vaccine against Porcine Cysticercosis, called Cysvax.
This innovation showcases IIL's commitment to developing cutting-edge solutions for animal health.
IIL is the only producer of companion animal vaccines in India, catering to the needs of pet owners.
The company has also partnered with the Indian Council of Agricultural Research (ICAR) to advance its fish vaccine development efforts through a collaboration agreement with ICAR-CIBA.
For another approach, see: Eros Media World
Human Biologicals Institute

The Human Biologicals Institute (HBI) is a division of Indian Immunologicals Ltd, involved in the Human Health Business.
HBI was established in 1999 to manufacture modern Tissue Culture Anti Rabies Vaccine (TCARV) for human use at Ooty, Tamil Nadu.
This institute operates a manufacturing facility in Ooty to produce the Vero cell culture rabies vaccine for human use, which meets a large part of the requirements of the Universal Immunization Programme of the Ministry of Health, Govt of India.
HBI has emerged as a leading player in the vaccine segment in India and Nepal, and has also forayed into the market of clinically proven wellness products and infertility range of hormones.
Indian Immunologicals' HBI is involved in the development of a Zika vaccine in collaboration with the Indian Council of Medical Research.
The institute is one of the leading suppliers of Animal Health and Human Health products to the State and Central Government ministries and its agencies.
Legal Entities Associated

Let's take a closer look at the legal entities associated with some of these companies. Indian Immunologicals Limited is a great example, with a date of incorporation on October 8, 1999. They have a revenue of $169M as of March 31, 2024.
One notable company is Moderna, which was founded in 2010 in Cambridge, United States. It's a public company with a total funding of $2.78B. Moderna is known for developing mRNA-based therapeutics for a wide range of diseases.
Indian Immunologicals Limited is a company based in Hyderabad, India, and it was founded in 1982. They are a manufacturer of animal and human vaccines. Their Tracxn Score is 52/100.
Here's a list of the top 5 companies in the article section, along with their date of incorporation and revenue:
Founders and Board
The founders and board of Indian Immunologicals are a group of dedicated individuals who have been instrumental in shaping the company's vision and direction. K Anand Kumar serves as the Managing Director and has been a part of the team for over 11 years.

Meeneshkumar Champaklal Shah is an independent board member who has been serving the company for over 3 years. He is one of the many independent board members who bring a wealth of experience and expertise to the table.
Here is a list of the current independent board members:
- Meeneshkumar Champaklal Shah: 3 years 11 months
- flulsb: 3 years 6 months
- ydbboze: 2 years 5 months
- bgpsykq: 6 years 5 months
- kjsehpa: 5 years 4 months
- ngdixet: 3 years 6 months
- csxjiim: 2 years 4 months
These individuals bring a diverse range of skills and perspectives to the board, ensuring that the company is well-equipped to tackle the challenges of the industry.
Funding and Operations
Indian Immunologicals Limited is a leading vaccine manufacturer in India, with a strong focus on research and development. The company was founded in 1987 by the National Institute of Immunology and the Indian Council of Medical Research.
The company's initial funding came from the Department of Biotechnology, Government of India. This support enabled the company to establish its research and development capabilities.
Indian Immunologicals Limited has a robust operational setup, with a state-of-the-art manufacturing facility in Hyderabad. The facility has a capacity to produce over 100 million doses of vaccines per year.
Readers also liked: Projects and Development India Limited

The company's operations are guided by a strong commitment to quality and safety. It adheres to global standards and regulations, including those set by the World Health Organization.
The company's strong operational setup has enabled it to supply vaccines to over 100 countries worldwide. Its vaccines have been recognized for their quality and efficacy by various international organizations.
For more insights, see: Quality Chemicals Limited
Governance and Reports
Indian Immunologicals Limited has a robust governance structure in place. The company is led by a board of directors that includes prominent figures from the industry.
The board of directors is responsible for making key strategic decisions for the company. They ensure that the company's operations are in line with its vision and mission.
The company's board of directors has a diverse range of experience and expertise. They bring a wealth of knowledge and understanding to the table.
The board of directors meets regularly to discuss and review the company's performance. They also make decisions on major projects and initiatives.
Indian Immunologicals Limited is committed to transparency and accountability. The company publishes its annual reports, which provide a detailed overview of its financial performance and operations.
The annual reports are available on the company's website. They provide stakeholders with valuable insights into the company's performance and progress.
Featured Images: pexels.com


